Patent 8198284 was granted and assigned to National Health Research Institutes on June, 2012 by the United States Patent and Trademark Office.
A method for treating a neurodegenerative disorder. The method includes administering to a subject in need thereof an effective amount of one or more thiourea compounds of formula (I) or (II):